Actinium Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Actinium Pharmaceuticals's total funding is $106.1M.
Employee Data
- Actinium Pharmaceuticals has 56 Employees.
- Actinium Pharmaceuticals grew their employee count by 0% last year.
Actinium Pharmaceuticals Competitors & Alternatives
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $231M | 1490 | 47% | N/A | N/A |
#2 | $7.4M | 48 | -33% | N/A | N/A |
#3 | N/A | 56 | 0% | $106.1M | N/A |
#4 | $7.6M | 49 | N/A | N/A | N/A |
What Is Actinium Pharmaceuticals?
Actinium Pharmaceuticals, Inc. is engaged in the development and commercialization of alpha particle immunotherapeutics based on its unique patent position for the utilization of actinium-225 and bismuth-213. It has facilities in Florham Park, New Jersey and Oak Ridge, Tennessee.
keywords:N/A
$106.1M
Total Funding
56
Number of Employees
N/A
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Actinium Pharmaceuticals News
Actinium Pharmaceuticals, Inc. to Highlight Iomab-B Pivotal Phase 3 SIERRA Trial Data at the Transplantation & Cellular Therapy Tandem Meetings...
Data Supports Actinium Pharmaceutical's research collaboration with AVEO Oncology to develop and advance a HER3 targeted radiotherapy to...
Actinium Pharmaceuticals, Inc. and Immedica Announce Commercialization Agreement for Iomab-B (131I apamistamab) in Europe, the Middle East and...
Other Companies in Sydney
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.1M | 56 | 33% | N/A |
#2 | $12.8M | 56 | 0% | N/A |
#3 | $11.8M | 56 | N/A | N/A |
#4 | $10.6M | 56 | 8% | N/A |
#5 | $12.8M | 56 | -15% | N/A |
